NR1H4 and metabolic dysfunction-associated steatotic liver disease: Interestingly, FXR regulon activity showed an inverse correlation with basement membrane components and was lower in patients with worse clinical outcomes, emphasizing the potential benefits of FXR agonism as a therapeutic strategy in MASLD.